← Back to Search

Behavioral Intervention

Vocal-Social Reinforcement for Infant Speech Learning With Hearing Loss

N/A
Recruiting
Led By Sarah W Bottjer, Ph.D.
Research Sponsored by University of Southern California
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Infants ca. 7-16 months of age at study onset
Be younger than 18 years old
Must not have
Infants who are not exposed to English or Spanish in the home
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed at 16 months and/or 6 months after initial visit
Awards & highlights
No Placebo-Only Group

Summary

This trial studies how social factors influence how infants aged 7-18 months learn speech, with a focus on how those with hearing loss can benefit from extra reinforcement.

Who is the study for?
This study is for infants about 7-18 months old with either typical hearing or sensorineural hearing loss. They must have at least one parent who speaks English or Spanish and can participate in the study. Infants not exposed to these languages, or without a participating parent, cannot join.
What is being tested?
The trial examines how social interactions affect speech learning in infants. It involves parents playing with their child and saying nonsense words, which are then played back to the infant to see if it influences vocal learning.
What are the potential side effects?
Since this study focuses on social interaction and vocal exercises rather than medical interventions, there are no direct side effects associated with traditional clinical trials.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My child is between 7 and 16 months old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My infant is not exposed to English or Spanish at home.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed at 16 months and/or 6 months after initial visit
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed at 16 months and/or 6 months after initial visit for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Vocal Codes During Study Visit
Secondary study objectives
Change in Vocal Codes Between Visits
MacArthur Communicative Development Inventory
Perception

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ExperimentalExperimental Treatment1 Intervention
Parents are instructed to say nonsense words in response to infant babbles with a conserved phonological form as infant plays.
Group II: ControlActive Control1 Intervention
Parents are instructed to say nonsense words at random times with a conserved phonological form as infant plays.

Find a Location

Who is running the clinical trial?

Cornell UniversityOTHER
173 Previous Clinical Trials
14,089,488 Total Patients Enrolled
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
361 Previous Clinical Trials
181,938 Total Patients Enrolled
15 Trials studying Speech
1,931 Patients Enrolled for Speech
University of Southern CaliforniaLead Sponsor
946 Previous Clinical Trials
1,604,499 Total Patients Enrolled
Sarah W Bottjer, Ph.D.Principal InvestigatorUniversity of Southern California

Media Library

Vocal-Social Reinforcement (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05634356 — N/A
Speech Research Study Groups: Experimental, Control
Speech Clinical Trial 2023: Vocal-Social Reinforcement Highlights & Side Effects. Trial Name: NCT05634356 — N/A
Vocal-Social Reinforcement (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05634356 — N/A
~38 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top